10-propargyl-10-deazaaminopterin has been researched along with adenosine in 1 studies
Studies (10-propargyl-10-deazaaminopterin) | Trials (10-propargyl-10-deazaaminopterin) | Recent Studies (post-2010) (10-propargyl-10-deazaaminopterin) | Studies (adenosine) | Trials (adenosine) | Recent Studies (post-2010) (adenosine) |
---|---|---|---|---|---|
119 | 21 | 85 | 32,536 | 1,075 | 8,930 |
Protein | Taxonomy | 10-propargyl-10-deazaaminopterin (IC50) | adenosine (IC50) |
---|---|---|---|
high affinity choline transporter 1 isoform a | Homo sapiens (human) | 0.3851 | |
Sodium/nucleoside cotransporter 1 | Homo sapiens (human) | 5.5 | |
Sodium/nucleoside cotransporter 2 | Homo sapiens (human) | 5.5 | |
Adenosine receptor A3 | Homo sapiens (human) | 0.0011 | |
Adenosine receptor A1 | Homo sapiens (human) | 0.0023 | |
Equilibrative nucleoside transporter 1 | Homo sapiens (human) | 63 | |
Solute carrier family 28 member 3 | Homo sapiens (human) | 3.3 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
1 review(s) available for 10-propargyl-10-deazaaminopterin and adenosine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |